Companion Animal Vaccines Market to Reach USD 8,506.56 Million by 2034, Expanding at a CAGR of 8.0%

Companion Animal Vaccines Market

The companion animal vaccines market is rapidly evolving. This is driven by the growing emotional bonds with pets that have led to increased spending on their health and wellness, including routine vaccinations to support longer, healthier lives.

Get Exclusive Sample Pages of This Report: https://www.polarismarketresearch.com/industry-analysis/companion-animal-vaccines-market/request-for-sample

Market Size and Overview

The global companion animal vaccines market was valued at USD 3,943.84 million in 2024 and is projected to grow at a CAGR of 8.0% from 2025 to 2034.

Companion animal vaccines are immunizations developed to protect pets such as dogs, cats, and other domesticated animals from infectious diseases. These vaccines help strengthen the animal's immune system, prevent the spread of disease, and promote overall health and longevity. They play a vital role in routine veterinary care, covering conditions such as rabies, distemper, parvovirus, and feline leukemia.

Key Highlights from the Report

● Based on product, in 2024, the attenuated live vaccines segment held the largest market share, driven by their strong immunogenic response and rapid protection, especially important in environments prone to disease outbreaks. The recombinant vaccine sector is also projected to register the highest CAGR over the forecast period.
● By animal type, the canine segment held the largest market share, driven by substantial investments in canine healthcare and mandatory vaccination requirements for diseases such as leptospirosis, rabies, and distemper. The feline segment is also anticipated to record the highest CAGR during the forecast period.
● In 2024, North America held the largest companion animal vaccines market share, supported by strict pet vaccination regulations, widespread use of veterinary services, and a strong presence of pharmaceutical research and development.
● The Asia Pacific market is expected to record the highest CAGR during the forecast period, fueled by a rapidly expanding pet population, especially in emerging economies including India, China, and countries across Southeast Asia.

Major Driving Factors

Rising Pet Ownership and Humanization of Pets

The global increase in pet ownership, especially of dogs and cats, is shaping key trends in veterinary healthcare, including the growing demand for vaccines. As more pet owners regard their animals as family members, there is a rising preference for premium preventive care services.

Rising Awareness about Zoonotic Diseases

Rising concerns over zoonotic diseases have led to greater public and regulatory emphasis on preventive animal healthcare. Diseases, including leptospirosis, toxoplasmosis, and rabies, transmissible from pets to humans, have prompted governments and veterinary bodies to advocate for routine vaccinations to protect both animal and human health.

Request for a Discount on this Report Before Purchase: https://www.polarismarketresearch.com/industry-analysis/companion-animal-vaccines-market/request-for-discount-pricing

Top Companies

The companion animal vaccines market is experiencing growing competition, fueled by increased awareness of preventive care and a rising number of companion animal owners. Some of the top companies operating in the industry are:

Bimeda Biologicals
Boehringer Ingelheim Animal Health
Calier
Ceva
Elanco
Merck & Co., Inc.
Neogen Corporation
Phibro Animal Health Corporation
Virbac
Zoetis

Companion Animal Vaccines Industry Developments

July 2024: Biogénesis Bagó opened a new vaccine production facility in Campo Largo, Brazil, following a USD 30 million investment aimed at expanding its manufacturing capabilities.

June 2024: Merck Animal Health received USDA approval for its NOBIVAC NXT Canine Flu H3N2 vaccine, designed to protect dogs against canine influenza. The vaccine is expected to be available in veterinary clinics and hospitals across the U.S.

January 2022: Boehringer Ingelheim entered into a collaboration with MabGenesis to accelerate the discovery of novel monoclonal antibodies for canine health applications.

Market Segmentation

By Product Outlook

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

By Route of Administration Outlook

● Subcutaneous
● Intramuscular
● Intranasal

By Animal Type Outlook

● Canine
● Feline
● Others

By Distribution Channel Outlook

● Retail
● E-Commerce
● Hospital/ Clinic Pharmacy

Explore The Complete Comprehensive Report Here: https://www.polarismarketresearch.com/industry-analysis/companion-animal-vaccines-market

By Regional Outlook

● North America
○ US
○ Canada
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Netherlands
○ Russia
○ Rest of Europe
● Asia Pacific
○ China
○ Japan
○ India
○ Malaysia
○ South Korea
○ Indonesia
○ Australia
○ Vietnam
○ Rest of Asia Pacific
● Middle East & Africa
○ Saudi Arabia
○ UAE
○ Israel
○ South Africa
○ Rest of Middle East & Africa
● Latin America
○ Mexico
○ Brazil
○ Argentina
○ Rest of Latin America

More Trending Latest Reports by Polaris Market Research:

https://www.polarismarketresearch.com/industry-analysis/human-papilloma-virus-testing-market

https://www.polarismarketresearch.com/industry-analysis/india-orthobiologics-market

https://www.polarismarketresearch.com/industry-analysis/india-orthobiologics-market

https://www.polarismarketresearch.com/industry-analysis/sterilization-services-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.